Virtu Financial LLC

Position in NNVC — Nanoviricides, Inc.

CIK 1533964 New York, NY

Position in NNVC

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$11,065

-$57,864 QoQ

Shares Held

12,160

-75.3% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. NNVC ranks #133 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	70,715	$3,728,094
2	VRTX	Vertex Pharmaceuticals Inc / Ma	7,634	$3,408,886
3	CNTA	Centessa Pharmaceuticals plc	67,775	$2,692,023
4	APLS	Apellis Pharmaceuticals, Inc.	54,785	$2,204,000
5	BMRN	Biomarin Pharmaceutical Inc	38,479	$2,173,678
6	IBRX	ImmunityBio, Inc.	262,298	$2,011,825
7	KALA	KALA BIO, Inc.	152,197	$1,316,504
8	IMUX	Immunic, Inc.	113,366	$1,258,362

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,065	12,160	-75.3%	Shares	Defined	2026-05-14
2025-06-30	$68,929	49,235	+77.4%	Shares	Defined	2025-08-12
2025-03-31	$32,463	27,747	-56.4%	Shares	Defined	2025-05-12
2024-12-31	$91,010	63,644	+471.3%	Shares	Defined	2025-02-11
2024-06-30	$19,160	11,140	-33.4%	Shares	Defined	2024-08-09
2023-12-31	$17,055	16,721	+44.3%	Shares	Defined	2024-02-26
2022-12-31	$12,861	11,587	-41.5%	Shares	Defined	2023-02-15
2021-09-30	$91,839	19,793	+86.3%	Shares	Defined	2021-11-12
2020-09-30	$40,807	10,627	-57.6%	Shares	Defined	2020-12-11
2020-06-30	$187,688	25,092	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.